Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AGN194204 (IRX4204) is inactive against RAR and is an orally active and selective RXR agonist with Kd values 0.4 nM, 3.6 nM and 3.8 nM and EC50s of 0.2 nM, 0.8 nM and 0.08 nM for RXRα, RXRβ and RXRγ, respectively. AGN194204 has anti-inflammatory and anticarcinogenic actions[1][2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,820.00 | |
50 mg | 8-10 weeks | $ 2,380.00 | |
100 mg | 8-10 weeks | $ 3,100.00 |
Description | AGN194204 (IRX4204) is inactive against RAR and is an orally active and selective RXR agonist with Kd values 0.4 nM, 3.6 nM and 3.8 nM and EC50s of 0.2 nM, 0.8 nM and 0.08 nM for RXRα, RXRβ and RXRγ, respectively. AGN194204 has anti-inflammatory and anticarcinogenic actions[1][2]. |
Targets&IC50 | RXRβ:0.8 nM (EC50), RXRβ:3.6 nM (kd), RXRα:0.2 nM (EC50), RXRα:0.4 nM (kd), RXRγ:0.08 nM (EC50), RXRγ:3.8 nM (kd) |
In vitro | AGN194204 (NRX194204; 1 μM; 72 hours; SK-BR-3 human breast cancer cells) treatment induces apoptosis in breast cancer cells[1]. AGN194204 (NRX194204; 0-100 nM; 24 hours; E, RAW cells) treatment blocks the ability of lipopolysaccharide and tumor necrosis factor-α to induce the release of nitric oxide and interleukin 6 and the degradation of IKBα in RAW264.7 macrophage-like cells[1]. |
In vivo | AGN194204 (NRX194204; 30-60 mg/kg; oral administration; daily; for 15 weeks; female A/J mice) treatment significantly reduces the number and size of tumors on the surface of the lungs. It reduces the total tumor volume per slide by 64% to 81% compared with the control group[1]. |
Synonyms | IRX4204, NRX194204, VTP 194204 |
Molecular Weight | 352.51 |
Formula | C24H32O2 |
CAS No. | 220619-73-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AGN194204 220619-73-8 Others IRX 4204 IRX-4204 AGN-194204 IRX4204 VTP-194204 NRX194204 VTP 194204 NRX-194204 VTP194204 NRX 194204 AGN 194204 inhibitor inhibit